[1] World Health Organization. Global tuberculosis report 2016.Geneva: World Health Organization ,2016 .
[2] 陆伟,傅衍勇.我国耐药结核病控制的现状与展望.结核病与肺部健康杂志,2016,5(4):259-261.
[3] 骨关节结核临床诊断与治疗进展及其规范化专题研讨会学术委员会.正确理解和认识骨与关节结核诊疗的若干问题.中国防痨杂志,2013,35(5):384-392.
[4] Theron G, Peter J, Calligaro G, et al. Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments . Sci Rep, 2014, 4: 5658.
[5] 孙雯雯,肖和平,吴福蓉,等.结核感染T细胞斑点试验在临床诊断为肺外结核患者中的价值评价.中国防痨杂志,2015,37(7):784-789.
[6] 黄芳,党丽云,孙惠平,等.三种分子生物学诊断技术对结核病诊断价值的比较.中华结核和呼吸杂志,2015, 38(9):680-685.
[7] 贾文韫,李元. Xpert MTB/RIF在骨关节结核患者快速诊断中的应用.中国脊柱脊髓杂志, 2015, 25 (3): 208-212.
[8] Ketata W, Rekik WK, Ayadi H, et a1. Extrapulmonary tuberculosis. Rev Pneumol Clin, 2015, 71(2/3): 83-92.
[9] Magnussen A, Dinneen A, Ramesh P. Osteoarticular tuberculosis: increasing incidence of a difficult clinical diagnosis. Br J Gen Pract, 2013,63(612):385-386.
[10] 庄伟,石仕元,庄汝杰.骨与关节结核患者病灶感染病原菌检测结果分析.中华医院感染学杂志, 2015, 25 (2):401-403.
[11] 韩珍,林日文,骆妙卡,等.线性探针技术和传统基因检测技术在耐药结核病诊断中的可靠性和及时性对比.实验与检验医学,2015,33(2):150-153.
[12] Gu Y, Wang G, Dong W, et a1. Xpert MTB/RIF and Geno Type MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis. Int J Infect Dis, 2015,36:27-30.
[13] Sam IC, Drobniewski F, More P, et al. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis, 2006, 12(5):752-759.
[14] 李琦,张逸彪,雷敏.2008—2011年结核分枝杆菌的耐药性变迁.中华医院感染学杂志,2013,23(19): 4841-4843.
[15] Gupta R, Thakur R, Gupta P, et al. Evaluation of Geno Type MTBDRplus line probe assay for early detection of drug resistance in tuberculous meningitis patients in India. J Glob Infect Dis,2015,7(1):5-10.
[16] 赵珍,李月华,薛峰,等.2010—2014年新疆维吾尔自治区肺结核登记率变化趋势分析.中国防痨杂志, 2015, 37(7): 795-799. |